HELX
HELX
About Franklin Genomic Advancements ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
About Franklin Genomic Advancements ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 NTRA | Natera, Inc. | 7.34% | 6.58K | $1.67M |
 GH | Guardant Health, Inc. | 6.99% | 14.51K | $1.59M |
 MEDP | Medpace Holdings, Inc. | 4.59% | 1.71K | $1.05M |
 KRYS | Krystal Biotech, Inc. | 4.40% | 4.08K | $1.00M |
 BBIO | BridgeBio Pharma, Inc. | 3.66% | 11.26K | $835.91K |
 UTHR | United Therapeutics Corporation | 3.42% | 1.55K | $781.22K |
 ADPT | Adaptive Biotechnologies Corporation | 3.26% | 44.53K | $745.05K |
 LGND | Ligand Pharmaceuticals Incorporated | 3.07% | 3.50K | $700.46K |
 VRTX | Vertex Pharmaceuticals Incorporated | 2.81% | 1.32K | $641.50K |
 AZN | AstraZeneca PLC | 2.76% | 6.63K | $630.53K |
 LLY | Eli Lilly and Company | 2.66% | 548 | $607.23K |
 TEM | Tempus AI, Inc. | 2.60% | 8.51K | $593.88K |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.37% | 667 | $541.78K |
 WGS | GeneDx Holdings Corp. | 2.28% | 3.82K | $521.07K |
 EXAS | Exact Sciences Corporation | 2.17% | 4.86K | $494.33K |
 IONS | Ionis Pharmaceuticals, Inc. | 2.00% | 5.50K | $457.35K |
 CTVA | Corteva, Inc. | 1.91% | 6.37K | $436.81K |
 BNTX | BioNTech SE | 1.76% | 4.01K | $401.02K |
 GRAL | GRAIL, Inc. | 1.73% | 3.82K | $395.71K |
 TVTX | Travere Therapeutics, Inc. | 1.49% | 9.35K | $339.22K |
SECTOR HOLDINGS
Healthcare
Basic Materials
TechnologyASSET ALLOCATION BY REGION
United States.svg)
Korea (the Republic of)
United Kingdom
Germany
Netherlands
Switzerland
Ireland
Singapore
Cayman IslandsSECTOR HOLDINGS
Healthcare Basic Materials TechnologyASSET ALLOCATION BY REGION
United States Korea (the Republic of) United Kingdom Germany Netherlands Switzerland Ireland Singapore Cayman IslandsHoldings (Top 20)
NTRA
Natera, Inc.
GH
Guardant Health, Inc.
MEDP
Medpace Holdings, Inc.
KRYS
Krystal Biotech, Inc.
BBIO
BridgeBio Pharma, Inc.
UTHR
United Therapeutics Corporation
ADPT
Adaptive Biotechnologies Corporation
LGND
Ligand Pharmaceuticals Incorporated
VRTX
Vertex Pharmaceuticals Incorporated
AZN
AstraZeneca PLC
LLY
Eli Lilly and Company
TEM
Tempus AI, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
WGS
GeneDx Holdings Corp.
EXAS
Exact Sciences Corporation
IONS
Ionis Pharmaceuticals, Inc.
CTVA
Corteva, Inc.
BNTX
BioNTech SE
GRAL
GRAIL, Inc.
TVTX
Travere Therapeutics, Inc.